Breaking Biometric News: Profile Solutions (OTC: PSIQ) Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board

PSI to Develop Biometric Security Solutions for Cannabis Markets

FT LAUDERDALE, Fla. - April 27, 2015 (Investorideas.com Newswire) Profile Solutions, Inc. (OTC PK: PSIQ), a leading solution provider of access control and security systems is pleased to announce that Dr Gerry Bedore has joined the company as a consultant and member of its scientific advisory board.

Gerry Bedore is widely known as a thought leader in technology-enhanced learning models. He was a co-founder of Socrates Distance Learning Technology Group, and has published studies and books focused on online student success and completion rates. Gerry is recognized as having developed many of the most successful higher education online programs in the world. As a horticulturist for the State of Georgia, Dr. Bedore was recognized for his expertise in entomology and pathology in the care of plant life in the state. He has authored one book, co-authored two books, and has served as a research chair and committee member for more than 200 studies in education, psychology and business disciplines.

Read more: Breaking Biometric News: Profile Solutions (OTC: PSIQ) Names Medicinal Cannabis, Agriculture and...

Breaking Tech News: Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers

NXT-ID, Inc (Nasdaq:NXTD; NXTDW) Reports Shipments Begin First Week ofMay

OXFORD, Conn. - April 27, 2015 (Investorideas.com Newswire) NXT-ID, Inc. (NASDAQ: NXTD; NXTDW), a biometric authentication company focused on the growing mobile commerce market, announces that its Wocket® Smart Wallet will commence shipping to pre-order customers the first week of May, 2015 and will be fulfilling all paid pre-orders through the month of May.

Gino Pereira, Chief Executive Officer said, "This is a significant milestone for the company as Wocket® enters the consumer market. We would like to express our appreciation to all our pre-order customers that have waited patiently to receive this revolutionary product."

Read more: NXT-ID Inc ( NXTD )

Medical Technology Breaking News: Aethlon Medical (OTC: AEMD, AEMDD) Discloses Presentation of Preliminary CTE Related Study Results

SAN DIEGO - April 16, 2015 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCQB: AEMD, AEMDD), a pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, announced today that Dr. Robert Stern, professor of neurology, neurosurgery, and anatomy and neurobiology at Boston University School of Medicine (BUSM) has presented preliminary, unpublished findings related to research being conducted by Aethlon Medical's majority owned subsidiary, Exosome Sciences, Inc. The presentation was given earlier today at the 5th Annual Traumatic Brain Injury Conference being held in Washington, D.C.

Read more: Aethlon Medical ( AEMD )

Tech News: SNS FiRe Conference Names NXT-ID (Nasdaq:NXTD; NXTDW) a 2015 FiReStarter Company

Global Thought Leaders Converge to Work on Solving Some of the World's Greatest Challenges in Real-Time

FRIDAY HARBOR, WA - April 15, 2015 (Investorideas.com Newswire) Strategic News Service (SNS) is proud to announce that NXT-ID (NASDAQ: NXTD) has been selected as a 2015 FiReStarter company to be featured at the 13th annual Future in Review (FiRe) conference.

Described by The Economist as "the best technology conference in the world," FiRe features global thought leaders in technology and the global economy, including Elon Musk, Craig Venter, Michael Dell, Vint Cerf, Leroy Hood, Patti Grace Smith, Mark Hurd, Paul Jacobs, and many others. FiReStarters are selected based on the strength of their innovations and their potential to bring positive change to the world, and are showcased at an exclusive investor reception at the FiRe conference, in panels throughout the event, and with ongoing relationships introduced and supported by SNS.

Read more: SNS FiRe Conference Names NXT-ID (Nasdaq:NXTD; NXTDW) a 2015 FiReStarter Company

Medical Technology Breaking News: Aethlon Medical (OTC: AEMDD) Announces Cancer Clinical Trial Agreement

SAN DIEGO - April 15, 2015 (Investorideas.com newswire) Aethlon Medical, Inc. (OTC:AEMDD), a pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, announced today that it has entered into an investigator-initiated clinical trial agreement with the University of California, Irvine (UCI). Under the agreement, a clinical study protocol entitled, "Plasma Exosome Concentration in Cancer Patients Undergoing Treatment," will seek to enroll five individuals in each of nine defined tumor types for a total study population of up to 45 subjects. The tumor types include the following forms of cancer; Breast adenocarcinoma, Colorectal, Gastric & Gastroesophageal, Pancreatic, Cholangiocarcinoma, Lung (NSCLC), Head & Neck (SCC), Melanoma and Ovarian adenocarcinoma. The principal investigator of the study is Edward Nelson, M.D.

Read more: Aethlon Medical ( AEMDD )